Metastatic Colorectal Cancer Surgery Market

Colorectal cancer is the third most common type cancer and represents 9.7% of total cancer cases across the globe. According to American Cancer Society colorectal cancer is treatable and curable when it is localized to the bowel. However, colorectal cancer cancers that have spread to other body parts i.e. metastatic colorectal cancers are difficult to treat and have 11%-12% 5-year relative survival rate.

Metastatic Colorectal Cancer Surgery Market contains market size and forecasts of Metastatic Colorectal Cancer Surgery in Global, including the following market information:

• Global Metastatic Colorectal Cancer Surgery Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global top five companies in 2021 (%)

The global Metastatic Colorectal Cancer Surgery market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Tumor Resection Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Metastatic Colorectal Cancer Surgery include Sanofi, Roche, Eli Lilly, Pfizer, Novartis, Amgen, Taiho Oncology, Genentech and EMD Serono and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Metastatic Colorectal Cancer Surgery companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Metastatic Colorectal Cancer Surgery Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Metastatic Colorectal Cancer Surgery Market Segment Percentages, by Type, 2021 (%)

• Tumor Resection
• Portal Vein Embolization

Global Metastatic Colorectal Cancer Surgery Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Metastatic Colorectal Cancer Surgery Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics
• Cancer Research Centers

Global Metastatic Colorectal Cancer Surgery Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Metastatic Colorectal Cancer Surgery Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Metastatic Colorectal Cancer Surgery revenues in global market, 2017-2022 (estimated), ($ millions)
• Key companies Metastatic Colorectal Cancer Surgery revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Sanofi
• Roche
• Eli Lilly
• Pfizer
• Novartis
• Amgen
• Taiho Oncology
• Genentech
• EMD Serono
• Suzhou Zelgen Biopharmaceuticals